-
Preserving the Future
Young adults undergoing cancer treatment who may want to have children should talk with their doctors about ways to preserve their fertility.
by Marci A. Landsmann
-
In the Moment- Summer 2015
Beverly McKee, Charlie Haygood, Patricia Fernandes.
-
The DCIS Dilemma
Ductal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
-
Survivor Profile
A Desire to HelpSince P.J. Lukac's glioblastoma diagnosis, the young pediatrician has worked hard to spread awareness and understanding of the disease.
by Stephen Ornes
-
Yesterday & Today
The Voice of Lamb ChopVentriloquist Shari Lewis and her sidekick, a white wool puppet named Lamb Chop, won the hearts of generations of children who tuned in to her television shows.
by Jocelyn Selim
-
The Cost of Cancer
Expensive treatments can leave patients with a mountain of debt. Resources are available to help.
by Bara Vaida
-
Survivor Profile
An Unplanned EventAfter a stage III cancer diagnosis, event planner Kim Hall Jackson gave up the illusion of control and started using her talents to promote screening among African-Americans.
by Leigh Labrie
-
The Ways We Approach Death
Cancer often requires making difficult decisions in the face of uncertainty.
by Sue Rochman
-
Yesterday & Today
Improbable ChampionSusan Butcher won Alaska's grueling Iditarod dog-sled race four times. Her 2005 leukemia diagnosis marked the beginning of her greatest challenge.
by Jocelyn Selim
-
In the Moment- Spring 2015
Catie Clinard, Denise Manley Fox, David Frangioni.
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff